MEMBERS' HANDBOOK |
(Issued August 2002)
The enterprise recognises the deferred tax liability in years 1 to 4 because the reversal of the taxable temporary difference will create taxable income in subsequent years. The enterprise's income statement is as follows: | ||||||||||
Year |
||||||||||
1 |
|
2 |
|
3 |
|
4 |
|
5 |
||
$ |
|
$ |
|
$ |
|
$ |
|
$ |
||
Income |
2,000 |
|
2,000 |
|
2,000 |
|
2,000 |
|
2,000 |
|
Depreciation |
2,000 |
|
2,000 |
|
2,000 |
|
2,000 |
|
2,000 |
|
Profit before tax |
0 |
|
0 |
|
0 |
|
0 |
|
0 |
|
Current tax expense (income) |
(200) |
|
(200) |
|
(200) |
|
(200) |
|
800 |
|
Deferred tax expense (income) |
200 |
|
200 |
|
200 |
|
200 |
|
(800) |
|
Total tax expense (income) |
0 |
|
0 |
|
0 |
|
0 |
|
0 |
|
Net profit for the period |
0 |
|
0 |
|
0 |
|
0 |
|
0 |
|
|
|
|
|
|
|
|
|
|
Example 2 - Deferred Tax Assets and Liabilities
|
||||
Current Tax Expense | ||||
X5 |
|
X6 |
||
$ |
|
$ |
||
Accounting profit |
8,775 |
|
8,740 |
|
Add |
|
|
|
|
Depreciation for accounting purposes |
4,800 |
|
8,250 |
|
Charitable donations |
500 |
|
350 |
|
Fine for environmental pollution |
700 |
|
- |
|
Product development costs |
250 |
|
250 |
|
Provision for health care benefits |
2,000 |
|
1,000 |
|
17,025 |
|
18,590 |
||
Deduct |
|
|
|
|
Depreciation for tax purposes |
(8,100) |
|
(11,850) |
|
Taxable Profit |
8,925 |
|
6,740 |
|
Current tax expense at 40% |
3,570 |
|
|
|
Current tax expense at 35% |
|
|
2,359 |
|
|
|
|
Carrying Amounts of Property, Plant and Equipment | ||||||
Building |
|
Motor Vehicles |
|
Total |
||
$ |
|
$ |
|
$ |
||
Cost |
|
|
|
|
|
|
Balance at 31/12/X4 |
50,000 |
|
10,000 |
|
60,000 |
|
Additions X5 |
6,000 |
|
- |
|
6,000 |
|
Balance at 31/12/X5 |
56,000 |
|
10,000 |
|
66,000 |
|
Elimination of accumulated depreciation on revaluation at 1/1/X6 |
(22,800) |
|
- |
|
(22,800) |
|
Revaluation at 1/1/X6 |
31,800 |
|
- |
|
31,800 |
|
Balance at 1/1/X6 |
65,500 |
|
10,000 |
|
75,000 |
|
Additions X6 |
- |
|
15,000 |
|
15,000 |
|
Balance at 31/12/X6 |
65,000 |
|
25,000 |
|
90,000 |
|
Accumulated Depreciation |
5% |
|
20% |
|
|
|
Balance at 31/12/X4 |
20,000 |
|
4,000 |
|
24,000 |
|
Depreciation X5 |
2,800 |
|
2,000 |
|
4,800 |
|
Balance at 31/12/X5 |
22,800 |
|
6,000 |
|
28,800 |
|
Revaluation at 1/1/X6 |
(22,800) |
|
- |
|
(22,800) |
|
Balance at 1/1/X6 |
- |
|
6,000 |
|
6,000 |
|
Depreciation X6 |
3,250 |
|
5,000 |
|
8,250 |
|
Balance at 31/12/X6 |
3,250 |
|
11,000 |
|
14,250 |
|
Carrying Amount |
|
|
|
|
|
|
31/12/X4 |
30,000 |
|
6,000 |
|
36,000 |
|
31/12/X5 |
33,200 |
|
4,000 |
|
37,200 |
|
31/12/X6 |
61,750 |
|
14,000 |
|
75,750 |
|
|
|
|
|
|
Tax Base of Property, Plant and Equipment | ||||||
Building |
|
Motor Vehicles |
|
Total |
||
$ |
|
$ |
|
$ |
||
Cost |
|
|
|
|
|
|
Balance at 31/12/X4 |
50,000 |
|
10,000 |
|
60,000 |
|
Additions X5 |
6,000 |
|
- |
|
6,000 |
|
Balance at 31/12/X5 |
56,000 |
|
10,000 |
|
66,000 |
|
Additions X6 |
- |
|
15,000 |
|
15,000 |
|
Balance at 31/12/X6 |
56,000 |
|
25,000 |
|
81,000 |
|
Accumulated Depreciation |
10% |
|
25% |
|
|
|
Balance at 31/12/X4 |
40,000 |
|
5,000 |
|
45,000 |
|
Depreciation X5 |
5,600 |
|
2,500 |
|
8,100 |
|
Balance at 31/12/X5 |
45,600 |
|
7,500 |
|
53,100 |
|
Depreciation X6 |
5,600 |
|
6,250 |
|
11,850 |
|
Balance 31/12/X6 |
51,200 |
|
13,750 |
|
64,950 |
|
Tax Base |
|
|
|
|
|
|
31/12/X4 |
10,000 |
|
5,000 |
|
15,000 |
|
31/12/X5 |
10,400 |
|
2,500 |
|
12,900 |
|
31/12/X6 |
4,800 |
|
11,250 |
|
16,050 |
|
|
|
|
|
|
Deferred Tax Assets, Liabilities and Expense at 31/12/X4 | ||||||
Carrying Amount |
|
Tax Base |
|
Temporary Differences |
||
$ |
|
$ |
|
$ |
||
Accounts receivable |
500 |
|
500 |
|
- |
|
Inventory |
2,000 |
|
2,000 |
|
- |
|
Product development costs |
500 |
|
- |
|
500 |
|
Investments |
33,000 |
|
33,000 |
|
- |
|
Property, plant & equipment |
36,000 |
|
15,000 |
|
21,000 |
|
TOTAL ASSETS |
72,000 |
|
50,500 |
|
21,500 |
|
Current income taxes payable |
3,000 |
|
3,000 |
|
- |
|
Accounts payable |
500 |
|
500 |
|
- |
|
Fines payable |
- |
|
- |
|
- |
|
Liability for health care benefits |
- |
|
- |
|
- |
|
Long term debt |
20,000 |
|
20,000 |
|
- |
|
Deferred income taxes |
8,600 |
|
8,600 |
|
- |
|
TOTAL LIABILITIES |
32,100 |
|
32,100 |
|
|
|
Share capital |
5,000 |
|
5,000 |
|
- |
|
Revaluation surplus |
- |
|
- |
|
- |
|
Retained earnings |
34,900 |
|
13,400 |
|
|
|
TOTAL LIABILITIES / EQUITY |
72,000 |
|
50,500 |
|
|
|
TEMPORARY DIFFERENCES |
|
|
|
|
21,500 |
|
|
|
|
|
|
||
Deferred tax liability |
21,500 at 40% |
|
8,600 |
|||
Deferred tax asset |
- |
|
|
|
- |
|
Net deferred tax liability |
|
|
|
|
8,600 |
|
|
|
|
|
|
Deferred Tax Assets, Liabilities and Expense at 31/12/X5 | ||||||
Carrying Amount |
|
Tax Base |
|
Temporary Differences |
||
$ |
|
$ |
|
$ |
||
Accounts receivable |
500 |
|
500 |
|
- |
|
Inventory |
2,000 |
|
2,000 |
|
- |
|
Product development costs |
250 |
|
- |
|
250 |
|
Investments |
33,000 |
|
33,000 |
|
- |
|
Property, plant & equipment |
37,200 |
|
12,900 |
|
24,300 |
|
TOTAL ASSETS |
72,950 |
|
48,400 |
|
24,550 |
|
Current income taxes payable |
3,570 |
|
3,570 |
|
- |
|
Accounts payable |
500 |
|
500 |
|
- |
|
Fines payable |
700 |
|
700 |
|
- |
|
Liability for health care benefits |
2,000 |
|
- |
|
(2,000) |
|
Long term debt |
12,475 |
|
12,475 |
|
- |
|
Deferred income taxes |
9,020 |
|
9,020 |
|
- |
|
TOTAL LIABILITIES |
28,265 |
|
26,265 |
|
(2,000) |
|
Share capital |
5,000 |
|
5,000 |
|
- |
|
Revaluation surplus |
- |
|
- |
|
- |
|
Retained earnings |
39,685 |
|
17,135 |
|
|
|
TOTAL LIABILITIES / EQUITY |
72,950 |
|
48,400 |
|
|
|
TEMPORARY DIFFERENCES |
|
|
|
|
22,550 |
|
|
|
|
|
|
||
Deferred tax liability |
24,550 at 40% |
|
9,820 |
|||
Deferred tax asset |
(2,000 ) at 40% |
|
(800 ) |
|||
Net deferred tax liability |
|
|
|
|
9,020 |
|
Less: Opening deferred tax liability |
|
|
|
|
(8,600 ) |
|
Deferred tax expense (income) related to the origination and reversal of temporary differences |
|
|
|
|
420 |
|
|
|
|
|
|
Deferred Tax Assets, Liabilities and Expense at 31/12/X6 | ||||||
Carrying Amount |
|
Tax Base |
|
Temporary Differences |
||
$ |
|
$ |
|
$ |
||
Accounts receivable |
500 |
|
500 |
|
- |
|
Inventory |
2,000 |
|
2,000 |
|
- |
|
Product development costs |
- |
|
- |
|
- |
|
Investments |
33,000 |
|
33,000 |
|
- |
|
Property, plant & equipment |
75,750 |
|
16,050 |
|
59,700 |
|
TOTAL ASSETS |
111,250 |
|
51,550 |
|
59,700 |
|
Current income taxes payable |
2,359 |
|
2,359 |
|
- |
|
Accounts payable |
500 |
|
500 |
|
- |
|
Fines payable |
700 |
|
700 |
|
|
|
Liability for health care benefits |
3,000 |
|
- |
|
(3,000) |
|
Long term debt |
12,805 |
|
12,805 |
|
- |
|
Deferred income taxes |
19,845 |
|
19,845 |
|
- |
|
TOTAL LIABILITIES |
39,209 |
|
36,209 |
|
(3,000) |
|
Share capital |
5,000 |
|
5,000 |
|
- |
|
Revaluation surplus |
19,637 |
|
- |
|
- |
|
Retained earnings |
47,404 |
|
10,341 |
|
|
|
TOTAL LIABILITIES / EQUITY |
111,250 |
|
51,550 |
|
|
|
TEMPORARY DIFFERENCES |
|
|
|
|
56,700 |
|
Deferred tax liability |
59,700 at 35% |
20,895 |
||||
Deferred tax asset |
(3,000) at 35% |
(1,050 ) |
||||
Net deferred tax liability |
|
|
|
19,845 |
||
Less: Opening deferred tax liability |
|
|
|
(9,020) |
||
Adjustment to opening deferred tax liability resulting from reduction in tax rate |
22,550 at 5% |
1,127 |
||||
Deferred tax attributable to revaluation surplus |
31,800 at 35% |
(11,130 ) |
||||
Deferred tax expense (income) related to the origination and reversal of temporary differences |
822 |
|||||
Illustrative Disclosure |
||||
The amounts to be disclosed in accordance with the Statement are as follows: | ||||
Major components of tax expense (income) (paragraph 79) | ||||
X5 |
|
X6 |
||
$ |
|
$ |
||
Current tax expense |
3,570 |
|
2,359 |
|
Deferred tax expense relating to the origination and reversal of temporary differences: |
420 |
|
822 |
|
Deferred tax expense (income) resulting from reduction in tax rate |
- |
|
(1,127) |
|
Tax expense |
3,990 |
|
2,054 |
|
Aggregate current and deferred tax relating to items charged or credited to equity (paragraph 81(a)) | ||||
Deferred tax relating to revaluation of building |
- |
|
(11,130) |
|
In addition, deferred tax of $557 was transferred in X6 from retained earnings to revaluation reserve. This relates
to the difference between the actual depreciation on the building and equivalent depreciation based on the cost
of the building. Explanation of the relationship between tax expense and accounting profit (paragraph 81(c)) The Statement permits two alternative methods of explaining the relationship between tax expense (income) and accounting profit. Both of these formats are illustrated on the next page. |
||||
(i) | a numerical reconciliation between tax expense (income) and the product of accounting profit multiplied by the applicable tax rate(s), disclosing also the basis on which the applicable tax rate(s) is (are) computed | ||||
X5 |
|
X6 |
|||
$ |
|
$ |
|||
Accounting profit |
8,775 |
|
8,740 |
||
Tax at the applicable tax rate of 35% (X5: 40%) |
3,510 |
|
3,059 |
||
Tax effect of expenses that are not deductible in determining taxable profit: |
|
|
|
||
Charitable donations |
200 |
|
122 |
||
Fines for environmental pollution |
280 |
|
- |
||
Reduction in opening deferred taxes resulting from reduction in tax rate |
- |
|
(1,127) |
||
Tax expense |
3,990 |
|
2,054 |
||
The applicable tax rate is the aggregate of the national income tax rate of 30% (X5: 35%) and the local income tax rate of 5%. | |||||
(ii) | a numerical reconciliation between the average effective tax rate and the applicable tax rate, disclosing also the basis on which the applicable tax rate is computed | ||||
X5 |
|
X6 |
|||
% |
|
% |
|||
Applicable tax rate |
40.0 |
|
35.0 |
||
Tax effect of expenses that are not deductible for tax purposes: |
|
|
|
||
Charitable donations |
2.3 |
|
1.4 |
||
Fines for environmental pollution |
3.2 |
|
- |
||
Effect on opening deferred taxes of reduction in tax rate |
- |
|
(12.9) |
||
Average effective tax rate (tax expense divided by profit before tax) |
45.5 |
|
23.5 |
||
The applicable tax rate is the aggregate of the national income tax rate of 30% (X5: 35%) and the local income tax rate of 5%. | |||||
An explanation of changes in the applicable tax rate(s) compared to the previous accounting period (paragraph 81(d)) | |||||
In X6, the government enacted a change in the national income tax rate from 35% to 30%. | |||||
In respect of each type of temporary difference, and in respect of each type of unused tax losses and unused tax credits: | |||||
(i) | the amount of the deferred tax assets and liabilities recognised in the balance sheet for each period presented; | ||||
(ii) | the amount of the deferred tax income or expense recognised in the income statement for each period presented, if this is not apparent from the changes in the amounts recognised in the balance sheet (paragraph 81(g)) | ||||
X5 |
|
X6 |
|||
$ |
|
$ |
|||
Accelerated depreciation for tax purposes |
9,720 |
|
10,322 |
||
Liabilities for health care benefits that are deducted for tax purposes only when paid |
(800) |
|
(1,050) |
||
Product development costs deducted from taxable profit in earlier years |
100 |
|
- |
||
Revaluation, net of related depreciation |
- |
|
10,573 |
||
Deferred tax liability |
9,020 |
|
19,845 |
||
(note: the amount of the deferred tax income or expense recognised in the income statement for the current year is apparent from the changes in the amounts recognised in the balance sheet.) | |||||
Example 3 - Business Combinations
|
||||||
Cost of Acquisition |
|
Tax Base |
|
Temporary Differences |
||
$ |
|
$ |
|
$ |
||
Property, plant and equipment |
270 |
|
155 |
|
115 |
|
Accounts receivable |
210 |
|
210 |
|
- |
|
Inventory |
174 |
|
124 |
|
50 |
|
Retirement benefit obligations |
(30) |
|
- |
|
(30) |
|
Accounts payable |
(120) |
|
(120) |
|
- |
|
Fair value of the identifiable assets and liabilities acquired, excluding deferred tax |
504 |
|
369 |
|
135 |
|
The deferred tax asset arising from the retirement benefit obligations is offset against the deferred tax liabilities
arising from the property, plant and equipment and inventory (see paragraph 74 of the Statement). No deduction is available in B's tax jurisdiction for the cost of the goodwill. Therefore, the tax base of the goodwill (in B's jurisdiction) is nil. However, in accordance with paragraph 15(a) of the Statement, A recognises no deferred tax liability for the taxable temporary difference associated, in B's tax jurisdiction, with the goodwill. |
||||||
The carrying amount, in A's consolidated financial statements, of its investment in B is made up as follows: | |
$ |
|
Fair value of identifiable assets and liabilities acquired, excluding deferred tax |
504 |
Deferred tax liability (135 at 40%) |
(54) |
Fair value of identifiable assets and liabilities acquired |
450 |
Goodwill (net of amortisation of nil) |
150 |
Carrying amount |
600 |
At the date of acquisition, the tax base, in A's tax jurisdiction, of A's investment in B is $600. Therefore, no
temporary difference is associated, in A's jurisdiction, with the investment. During X5, B's equity (incorporating the fair value adjustments made on acquisition) changed as follows: |
|
$ |
|
At 1 January X5 |
450 |
Retained profit for X5 (net profit of $150, less dividend payable of $80) |
70 |
At 31 December X5 |
520 |
A recognises a liability for any withholding tax or other taxes that it will suffer on the accrued dividend receivable
of $80. At 31 December X5, the carrying amount of A's underlying investment in B, excluding the accrued dividend receivable, is as follows: |
|
$ |
|
Net assets of B |
520 |
Goodwill (net of amortisation of $30) |
120 |
Carrying amount |
640 |
The temporary difference associated with A's underlying investment is $40 as follows: | |
$ |
|
Cumulative retained profit since acquisition |
70 |
Cumulative amortisation of goodwill |
(30) |
40 |
|
If A has determined that it will not sell the investment in the foreseeable future and that B will not distribute
its retained profits in the foreseeable future, no deferred tax liability is recognised in relation to A's investment
in B (see paragraphs 39 and 40 of the Statement). Note that this exception would apply for an investment in an
associate only if there is an agreement requiring that the profits of the associate will not be distributed in
the foreseeable future (see paragraph 42 of the Statement). A discloses the amount ($40) of the temporary difference
for which no deferred tax is recognised (see paragraph 81(f) of the Statement). If A expects to sell the investment in B, or that B will distribute its retained profits in the foreseeable future, A recognises a deferred tax liability to the extent that the temporary difference is expected to reverse. The tax rate reflects the manner in which A expects to recover the carrying amount of its investment (see paragraph 51 of the Statement). A credits or charges the deferred tax to equity to the extent that the deferred tax results from foreign exchange translation differences which have been charged or credited directly to equity (paragraph 61 of the Statement). A discloses separately: |
||||
(a) | the amount of deferred tax which has been charged or credited directly to equity (paragraph 81(a) of the Statement); and | |||
(b) | the amount of any remaining temporary difference which is not expected to reverse in the foreseeable future and for which, therefore, no deferred tax is recognised (see paragraph 81(f) of the Statement). | |||
Differences |
Reasons for the differences |
||||
|
There is currently no SSAP equivalent to IAS 32 which specifies the accounting treatment for a compound financial instrument. |
||||
|
There is currently no SSAP equivalent to IAS 32. |
||||
|
SSAP 2, which is the Hong Kong equivalent of IAS 8, does not permit the use of the allowed alternative treatment in IAS 8. |
(Note: The explanatory guidance and illustrative examples set out in the boxes within the body of SSAP 12 contain material that may not be based on the examples in IAS 12 but based on those in Australian Standard AASB 1020, Income Taxes.)